Vistin Pharma ASA (FRA:VP4)
Germany
· Delayed Price · Currency is EUR 1.660
+0.005 (0.30%)
Last updated: Dec 4, 2025, 9:11 AM CET
Vistin Pharma ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 78.06 | 62.75 | 45.6 | -4.72 | 24.87 | -96.96 | Upgrade
|
| Depreciation & Amortization | 21.57 | 19.03 | 17.35 | 12.28 | 10.61 | 9.62 | Upgrade
|
| Other Operating Activities | 22.02 | 17.7 | 12.92 | -1.29 | 7.13 | -27.31 | Upgrade
|
| Change in Accounts Receivable | -3.12 | -3.12 | 12.14 | -20.81 | -12.76 | 2.16 | Upgrade
|
| Change in Inventory | 3.51 | 3.51 | 3.28 | -40.54 | -11.12 | -7.68 | Upgrade
|
| Change in Other Net Operating Assets | -42.36 | 7.99 | -0.69 | 44.57 | -5.05 | -25.56 | Upgrade
|
| Operating Cash Flow | 79.69 | 107.86 | 90.59 | -10.51 | 13.68 | -145.73 | Upgrade
|
| Operating Cash Flow Growth | -20.20% | 19.06% | - | - | - | - | Upgrade
|
| Capital Expenditures | -14.79 | -40.8 | -17.9 | -64.29 | -31.94 | -53.1 | Upgrade
|
| Other Investing Activities | 0.51 | 0.51 | 0.22 | 0.03 | 0.27 | 1.73 | Upgrade
|
| Investing Cash Flow | -14.28 | -40.3 | -17.68 | -64.26 | -31.68 | -51.38 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 45.14 | - | - | Upgrade
|
| Total Debt Issued | - | - | - | 45.14 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -45.14 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.2 | -0.9 | -2.59 | -0.84 | -0.43 | Upgrade
|
| Total Debt Repaid | -1.2 | -1.2 | -46.05 | -2.59 | -0.84 | -0.43 | Upgrade
|
| Net Debt Issued (Repaid) | -1.2 | -1.2 | -46.05 | 42.55 | -0.84 | -0.43 | Upgrade
|
| Common Dividends Paid | -77.6 | -77.59 | - | - | -22.17 | -44.35 | Upgrade
|
| Other Financing Activities | 11.16 | -2.19 | -2.1 | -2.09 | -0.29 | -0.75 | Upgrade
|
| Financing Cash Flow | -67.65 | -80.97 | -48.14 | 40.46 | -23.3 | -45.53 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | 0 | 0 | -0 | Upgrade
|
| Net Cash Flow | -2.24 | -13.41 | 24.77 | -34.31 | -41.29 | -242.64 | Upgrade
|
| Free Cash Flow | 64.9 | 67.05 | 72.69 | -74.8 | -18.26 | -198.83 | Upgrade
|
| Free Cash Flow Growth | 16.37% | -7.75% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 14.26% | 15.61% | 16.58% | -24.54% | -6.55% | -78.31% | Upgrade
|
| Free Cash Flow Per Share | 1.46 | 1.51 | 1.64 | -1.69 | -0.41 | -4.48 | Upgrade
|
| Cash Interest Paid | 2.19 | 2.19 | 2.1 | 2.09 | 0.29 | 0.75 | Upgrade
|
| Levered Free Cash Flow | 19.82 | 36.75 | 54.19 | -81.62 | -30.41 | -44.79 | Upgrade
|
| Unlevered Free Cash Flow | 19.82 | 38.21 | 55.61 | -80.28 | -30.19 | -44.28 | Upgrade
|
| Change in Working Capital | -41.97 | 8.38 | 14.73 | -16.78 | -28.92 | -31.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.